아페레시스 시장 규모, 점유율, 성장 분석 : 제품별, 시술별, 기술별, 용도별, 최종사용자별, 지역별 - 산업 예측(2026-2033년)

Apheresis Market size was valued at USD 3.45 Billion in 2024 and is poised to grow from USD 3.83 Billion in 2025 to USD 8.92 Billion by 2033, growing at a CAGR of 11.15% during the forecast period (2026-2033).

The apheresis market is witnessing robust expansion, fueled by an increasing incidence of various diseases and a growing need for safe blood components. Advances in technology are leading to the development of innovative apheresis techniques, enhancing procedural effectiveness. Supportive reimbursement policies and funding for apheresis treatments further bolster market dynamics. This therapy is gaining traction as both a primary and adjunct treatment for conditions such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, and autoimmune diseases. The continual introduction of new products significantly influences growth prospects. Nonetheless, challenges such as a shortage of trained professionals, concerns regarding blood safety, and high procedural costs need to be addressed to maintain the momentum of market growth. Overall, apheresis demonstrates promising potential in clinical applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Apheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Apheresis Market Segments Analysis

Global Apheresis Market is segmented by product, procedure, technology, application, end user and region. Based on Product, the market is segmented into Apheresis Disposals and Apheresis Devices. Based on Procedure, the market is segmented into Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, Photopheresis, LDL-apheresis, and Others. Based on technology, the market is segmented into Centrifugation, and Membrane Separation. Based on application, the market is segmented into Renal Diseases, Neurology, Haematology, Cancer, Autoimmune Diseases, Cardiovascular Diseases and others. Based on end user, the market is segmented into Blood Collection Centers & Blood Component Providers, Hospitals & Transfusion Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Apheresis Market

The increasing prevalence of chronic conditions, including cancer, autoimmune diseases, and cardiovascular disorders, significantly boosts the demand for apheresis procedures. Apheresis is essential for effectively managing these health issues, as it allows for the selective removal or collection of particular blood components. This targeted approach enhances patient care and treatment outcomes, making apheresis a vital component in the therapeutic landscape for individuals battling these serious illnesses. The ongoing emphasis on personalized medicine and improved health management strategies further supports the growth of the apheresis market, as healthcare providers seek innovative solutions to address complex medical challenges.

Restraints in the Apheresis Market

The apheresis market faces significant challenges due to the high costs linked to both the devices and the therapeutic procedures. The substantial financial investment needed for acquiring and maintaining these specialized devices can deter healthcare facilities from adopting them widely. Moreover, the complexities involved in the installation and operation of apheresis equipment may also impede market expansion. Compounding these issues is the limited awareness of apheresis techniques among potential blood donors, which can lead to a decline in participation, ultimately restricting the growth potential of the market. Thus, these factors collectively present considerable restraints on apheresis industry development.

Market Trends of the Apheresis Market

A significant market trend in the apheresis sector is the rising acceptance of personalized medicine and targeted therapies. As healthcare technology advances, there is an increasing focus on customizing treatments to align with individual patient needs, including their unique medical conditions, genetic markers, and responses to treatments. This personalized approach not only enhances therapeutic efficacy but also optimizes patient outcomes, resulting in improved care quality. Furthermore, the integration of advanced data analytics and biomarker identification is likely to propel innovation in apheresis technologies, driving demand for solutions that facilitate tailored therapeutic interventions across various medical conditions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Regulatory Landscape
• Top Investment Pockets
• Market Attractiveness Index
• Technology Advancement
• Market Ecosystem
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• Macro-Economic Indicators

Global Apheresis Market Size by Product & CAGR (2026-2033)

• Market Overview
• Apheresis Disposals
  • Centrifugal Apheresis Devices
  • Membrane Separators
• Apheresis Devices

Global Apheresis Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Plasmapheresis
• Plateletpheresis
• Erythrocytapheresis
• Leukapheresis
• Photopheresis
• LDL-apheresis
• Others

Global Apheresis Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Centrifugation
  • Continuous Flow Centrifugal
  • Intermittent Flow Centrifugation
• Membrane Separation

Global Apheresis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Renal Diseases
• Neurology
• Haematology
• Cancer
• Autoimmune Diseases
• Cardiovascular Diseases
• Others

Global Apheresis Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Blood Collection Centers & Blood Component Providers
• Hospitals & Transfusion Centers
• Others

Global Apheresis Market Size & CAGR (2026-2033)

• North America (Product, Procedure, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product, Procedure, Technology, Application, End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product, Procedure, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product, Procedure, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Procedure, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Terumo BCT, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerus Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kawasumi Laboratories (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica SPA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Holdings (JIMRO) (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytosorbents Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioelettronica S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guangzhou Daji Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing ZKSK Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infomed SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haier Biomedical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation